Therapy Areas: Devices
InspireMD secures CE Mark approval for CGuard Prime EPS under European MDR
13 June 2025 -

Medical device company InspireMD, Inc. (NASDAQ:NSPR) announced on Friday that it has received CE Mark certification under the Europ...

Crossject advances paediatric development of ZEPIZURE Junior for epilepsy crisis management
11 June 2025 - Pharmaceutical company Crossject (Euronext Growth Paris:ALCJ) on Wednesday announced progress in the development of ZEPIZURE Junior, its needle-free emergency treatment for paediatric e...
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
11 June 2025 - Medical device company Creo Medical Group plc (AIM: CREO) announced on Wednesday that it has received clearance from the U.S. Food and Drug Administration for its SpydrBlade Flex device...
Tissue Regenix secures CE and UKCA certifications for OrthoPure XT
9 June 2025 - Regenerative medical devices company Tissue Regenix Group plc (AIM: TRX) announced on Monday that it has received CE certification under the EU Medical Device Regulation and UKCA certifi...
Terumo Corporation expands stroke portfolio in EMEA with SOFIA Flow 88 catheter launch
2 June 2025 - US medical device company Terumo Neuro, a subsidiary of Terumo Corporation (TYO:4543), on Monday announced the commercial availability of the SOFIA Flow 88 Neurovascular Aspiration Cathe...
Crossject advances ZENEO manufacturing with scalable aseptic filling module ahead of product rollout
27 May 2025 - Pharmaceutical company Crossject (Euronext Growth Paris:ALCJ) announced on Tuesday the development and upcoming implementation of the ZENEO Nest, a new manufacturing module designed to e...